Chief Pharmacist
Pharmacogenomics
Pharmacogenomics is an advance field of pharmacy practice, which help to develop personalized medicine for a patient. Pharmacogenomics combines the ...
Regulatory Authorities
Regulatory authorities enforce legal frameworks for new drug products or medical devices approval in market. For example, US FDA oversees ...
Impurities
Impurities refer to unwanted substances or contaminants present in API or drug product. It can arise during manufacturing, handling, or ...
Innovator Drug
Innovator drug is a first time developed drug product through extensive research and clinical trials to demonstrate safety and efficacy. ...
Misbranded
A misbranded drug is a pharmaceutical product that has misleading information or false labeling or illegal advertising and violating regulatory ...
Over-the-Counter (OTC) Drug
OTC drugs are medications that can be purchased without a prescription for the treatment of minor ailments and conditions. As ...
Biodistribution (BD)
BD is the in vivo distribution, persistence, and clearance of a gene therapy (GT) product at the site of administration ...
Bioburden
The level and type (e.g. objectionable or not) of micro-organisms that can be present in raw materials, Active Pharmaceutical Ingredient ...
Biological Activity, Drugs and Matrix
Biological Activity The specific ability or capacity of the product to achieve a defined biological effect. Potency is the quantitative ...